News
After the the FDA declared an end to the shortage of GLP-1 medications, compounded versions of the drug must be out of the market by Thursday.
MIHPC's report highlights major disparities in drug prices across Michigan hospitals, showcasing the urgent need for transparency and accountability.
The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...
2d
Pharmaceutical Technology on MSNNovo Nordisk’s CEO to step down as weight loss market share plummetsNovo Nordisk is parting ways with its CEO Lars Fruergaard Jørgensen after the two parties mutually agreed that a change of ...
Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations.
FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said ...
President Donald Trump said his executive order on drug prices would lower some prices in half or more. But the details are ...
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...
With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had ...
Trump signs executive order, discussed "overweight" friend who was taking the "fat shot drug." It wasn't confirmed whether he meant Ozempic or Wegovy.
Our price comparison tech brings you the best Dyson vacuum deals on all the models currently on the market. But it's worth noting that each product line offers a slightly different use case.
He credits the transformation to berberine-based supplements from Oxford Natural, calling them “nature’s Ozempic ... with one posting a side-by-side comparison and the caption: “Fair ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results